OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP-1 acts on habenular avoidance circuits to control nicotine intake
Luis M. Tuesta, Zuxin Chen, Alexander Duncan, et al.
Nature Neuroscience (2017) Vol. 20, Iss. 5, pp. 708-716
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Semaglutide lowers body weight in rodents via distributed neural pathways
Sanaz Gabery, Casper G. Salinas, Sarah Juel Paulsen, et al.
JCI Insight (2020) Vol. 5, Iss. 6
Open Access | Times Cited: 429

Tobacco and nicotine use
Bernard Le Foll, Megan E. Piper, Christie D. Fowler, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 185

The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Mette Kruse Klausen, Morgane Thomsen, Gitta Wörtwein, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 625-641
Open Access | Times Cited: 110

Neurobiological Mechanisms of Nicotine Reward and Aversion
Lauren Wills, Jessica L. Ables, Kevin M. Braunscheidel, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 271-310
Open Access | Times Cited: 74

Dissociable hindbrain GLP1R circuits for satiety and aversion
Kuei-Pin Huang, Alisha A Acosta, Misgana Y. Ghidewon, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 585-593
Closed Access | Times Cited: 36

Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study
William Yang Wang, Nora D. Volkow, Nathan A. Berger, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2587-2598
Open Access | Times Cited: 24

GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Nicholas K. Smith, Troy A. Hackett, Aurelio Galli, et al.
Neurochemistry International (2019) Vol. 128, pp. 94-105
Open Access | Times Cited: 118

Habenular TCF7L2 links nicotine addiction to diabetes
Alexander Duncan, Mary P. Heyer, Masago Ishikawa, et al.
Nature (2019) Vol. 574, Iss. 7778, pp. 372-377
Open Access | Times Cited: 99

Mechanisms of Nicotine Addiction
Marina R. Picciotto, Paul J. Kenny
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 5, pp. a039610-a039610
Open Access | Times Cited: 93

Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats
Nicole S. Hernandez, Kelsey Y. Ige, Elizabeth G. Mietlicki‐Baase, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 10, pp. 2000-2008
Open Access | Times Cited: 92

Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol
Candan Yasemin Eren, Arya Yigit, Ramazan Efe Dogruoz, et al.
Frontiers in Behavioral Neuroscience (2021) Vol. 14
Open Access | Times Cited: 72

Understanding the habenula: A major node in circuits regulating emotion and motivation
Jessica L. Ables, Kwanghoon Park, Inés Ibañez–Tallon
Pharmacological Research (2023) Vol. 190, pp. 106734-106734
Open Access | Times Cited: 36

Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial
Sophia Lengsfeld, Thilo Burkard, Andrea Meienberg, et al.
EClinicalMedicine (2023) Vol. 57, pp. 101865-101865
Open Access | Times Cited: 28

Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes
William Wang, Nora D. Volkow, Nathan A. Berger, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 8, pp. 1016-1027
Closed Access | Times Cited: 13

IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
Nicolaus Bruns, Elizabeth H. Tressler, Leandro F. Vendruscolo, et al.
Pharmacological Research (2024) Vol. 207, pp. 107312-107312
Open Access | Times Cited: 12

An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1

Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse
Elisabet Jerlhag
Pharmacology & Therapeutics (2018) Vol. 196, pp. 1-14
Open Access | Times Cited: 79

Vagal Interoceptive Modulation of Motivated Behavior
James W. Maniscalco, Linda Rinaman
Physiology (2018) Vol. 33, Iss. 2, pp. 151-167
Open Access | Times Cited: 72

Prefrontal Regulation of Punished Ethanol Self-administration
Lindsay R. Halladay, Adrina Kocharian, Patrick T. Piantadosi, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 11, pp. 967-978
Open Access | Times Cited: 69

Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum
Shannon L. Wolfman, Daniel Gill, Fili Bogdanic, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 64

Activation of glucagon‐like peptide‐1 receptors in the nucleus accumbens attenuates cocaine seeking in rats
Nicole S. Hernandez, Bernadette O’Donovan, Pavel I. Ortinski, et al.
Addiction Biology (2017) Vol. 24, Iss. 2, pp. 170-181
Open Access | Times Cited: 62

Page 1 - Next Page

Scroll to top